Coronary perforation of distal diagonal branch followed by prolonged recurrent cardiac tamponade finally resolved with pericardiotomy : the potential risk of hydrophilic guide-wires by Januszek, Rafał et al.
Send Orders for Reprints to reprints@benthamscience.ae
The Open Cardiovascular Medicine Journal, 2017, 11, 61-65 61
1874-1924/17 2017  Bentham Open
The Open Cardiovascular Medicine
Journal
Content list available at: www.benthamopen.com/TOCMJ/
DOI: 10.2174/1874192401711010061
CASE REPORT
Coronary  Perforation  of  Distal  Diagonal  Branch  Followed  by
Prolonged  Recurrent  Cardiac  Tamponade  Finally  Resolved  with
Pericardiotomy  -  the  Potential  Risk  of  Hydrophilic  Guide-Wires
Rafał  Januszek1,*,  Krzysztof  Bartuś2,  Radosław  Litwinowicz2,  Artur  Dziewierz1,3  and  Łukasz
Rzeszutko1,4
12nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland
2Department of Cardiovascular Surgery and Transplantation, John Paul II Hospital, Krakow, Poland
32nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
4Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland
Received: December 12, 2016 Revised: January 25, 2017 Accepted: January 26, 2017
Abstract:
Purpose:
Coronary artery perforation (CAP) is a complication of percutaneous coronary interventions (PCIs). Hydrophilic guide-wires have
been shown to increase the probability of CAP. Depending on the size of perforations we adopt different treatments.
Case:
We present the case of a 73-year old male with coronary artery disease and severe aortic valve stenosis.  The patient was in the
process of qualifying for a transcatheter  aortic valve implantation.  Unfortunately,  CAP of the first  diagonal branch of the LAD
occurred  during  PCI.  Initially,  abrupt  bleeding to  the  pericardial  sac  was  primarily  restrained.  However,  in  the  following days,
pericardial bleeding became silent, prolonged and finally resulted in surgical pericardiotomy and surgical aortic valve replacement.
Conclusion:
This case depicts that in some cases, more aggressive endovascular treatment of CAP during the acute phase could decrease the
probability  of  future  radical  surgical  treatment.  Although,  in  other  cases,  avoiding  radical  endovascular  treatment  of  CAP  and
secondary necrosis along the distribution of the artery culminates in a higher risk for conversion to a surgical cardiac procedure.
Accurate primary assessment of CAP seriousness and careful observation after PCI could improve results and lead to avoiding severe
complications.
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1. INTRODUCTION
The  incidence  of  coronary  artery  perforation  (CAP)  during  percutaneous  coronary  interventions  (PCI)  varies
between 0.2-0.6%, and may rise to 3% when devices such as an atherotome or laser are used [1]. It is estimated that in
about 20% of cases, the angioplasty guide-wire is the cause of CAP. According to Ellis et al., CAP can be classified
into one of three types: type I: extraluminal crater without extravasation; type II: pericardial or myocardial blushing
without contrast streaming; type III: extravasation through perforation >1 mm with contrast streaming, and subtype III -
cavity spilling (CS), when  the  extravasation  streams  toward  an  anatomic  chamber  such  as the  coronary  sinus,  the
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atria  orventricles.[2].  CAP  may  be  contained  and  may  also  cause  serious  acute  complications  such  as  cardiac
tamponade,  myocardial  infarction,  malignant  arrhythmias  and  death  [2].  Cardiac  tamponade  occurs  in  11-46%  of
patients experiencing CAP after PCI [3]. It increases in higher Ellis stages of CAP. About 30% of these patients require
emergency surgery [3]. Hydrophilic polymer-coated guide-wires are very useful for crossing areas of severe stenosis
but  are  associated with a  higher  risk of  CAP,  especially  when trying to  cross  complex lesions such as:  occlusions,
bifurcations, long lesions and tortuous vessels [1, 4, 5]. Depending on the class of CAP and bleeding intensity it could
be treated less or more invasively. In mild cases, protamine infusion or catheter balloon treatment is used [1, 4]. Other
possible treatments include: covered stents, coils and organic substances for artery occlusion [1, 4].
2. CASE
A 73-year-old male was admitted due to severe symptomatic aortic stenosis for further diagnosis and treatment. The
patient demonstrated with hypertension and history of ischaemic cerebral stroke 2 months prior to presentation. An
echocardiography  confirmed  severe  aortic  stenosis  with  an  aortic  valve  area  of  0.4-0.5  cm2  and  the  transvalvular
gradient of 74/48 mmHg. The left ventricle ejection fraction was 60%, with mild hypokinesis of the anterior wall and
anterior part of the interventricular septum. Carotid artery ultrasound revealed critical stenosis of the left internal carotid
artery (95%). Coronary angiography showed 80% stenosis of the left anterior descending artery (LAD) in the proximal
part including the first diagonal branch (Dg) (Fig. 1A). After coronary angiography, the case was discussed among our
“Heart  team”  and  the  patient  was  scheduled  for  subsequent  transcatheter  aortic  valve  implantation,  percutaneous
coronary intervention (PCI) of the proximal LAD and carotid artery stenting. PCI of the LAD was performed. One 6
French Extra  Backup 4.0  guide catheter  was used,  a  BMW Universal  II  (Abbott  Vascular,  Santa  Clara,  California,
USA) guide-wire was placed in the LAD, and after several attempts with other non-hydrophilic wires, ASAHI Sion
Black (Abbott Vascular, Santa Clara, California, USA) was placed in the first diagonal branch. Predilatation with a
balloon catheter (3.0 x 12 mm 10 atm.) was performed in the proximal Dg (Fig. 1B). Afterwards, we implanted a DES
Resolute stent (3.5 x 22 mm in LAD 16 atm.) (Fig. 1C). The Proximal Optimization Technique (POT) was performed
with a non-compliant balloon catheter (3.5 x 6 mm up to 20 atm.) We visualized a type B dissection in the proximal
edge of the stent which we placed in the LAD. There was no contrast extravasation before removal of the guide-wire
located in the Dg (Fig. 1D). Immediately after removing the guide-wire from the Dg, contrast extravasation appeared
distally (Figs. 2A, 2B). Due to the increase of clinical features of cardiac tamponade (drop in blood pressure to 80/60
mmHg)  and  in  subsequent  coronary  angiographies,  there  was  no  response  to  pharmacological  treatment,
pericardiocentesis  was  performed.  A  total  of  300  ml  of  blood  was  removed  with  resolution  of  clinical  tamponade
symptoms. After clinical stabilization, a Fielder XT-A guide-wire was put into the Dg. Afterwards, two unsuccessful
passages through stenotic lesions were attempted with 1.5 x 15 mm and 1.25 x 10 mm balloon catheters. The same
difficulties appeared with the use of a Finecross micro-catheter. Due to the hemodynamic destabilization, we decided to
finish the procedure and give the patient 30 mg of protamine sulphate. Over the next several hours after the procedure,
180 ml of blood was removed from the pericardium. Two days after the procedure, pericardial effusion stabilized and
the pericardial catheter was removed. Due to progressive anaemia, the patient was transfused 2 units of packed red
blood cells 8 days after the CAP. Increased pericardial blood was noted 10 days after the procedure and the pericardial
sac was punctured again resulting in the removal of 680 ml of blood. In the following three days, 440 ml and 480 ml
were removed from the pericardium. Fifteen days after the PCI coronary, the angiography revealed no signs of contrast
extravasation  (Fig.  2C).  The  patient  was  discussed  by  the  “Heart  team” and  scheduled  for  surgical  revision  of  the
pericardial sac, concomitant aortic valve replacement surgery and left internal carotid artery endarterectomy, scheduled
for the sixteenth day after the PCI. During surgical revision, several clots, haemolyzed blood and signs of pericardial
adhesions  and inflammation were  seen in  the  pericardium.  The operation was  performed with  hypothermia  (32°C),
extracorporeal circulation and crystalline cardioplegia. After the surgical opening of the ascending aorta, the pathologic
aortic  valve  was removed and replaced with  a  new biological  aortic  valve  Medtronic  Hancock II  23 A (Medtronic
Minneapolis,  MN,  USA).  Decompression  of  the  tamponade  was  performed  and  clots  were  removed.  Interestingly,
bleeding from the entire surface of the pericardium and visible signs of inflammation were seen. Laboratory tests did
not show decreased platelets (165,000/µl), prothrombin time was 14.1 sec, and activated partial thromboplastin time
was 40.5 sec on the day of surgery. During the cardiac surgery and postoperative period, the patient required transfusion
of 6 units of packed red blood cells. The postoperative period was uneventful. The patient was discharged 7 days after
the operation and transferred back to the referring hospital for further treatment.
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Fig. (1). Fluoroscopic images of left coronary artery during PCI. A - Cine image of LAD/Dg stenosis. B - Cine image of LAD/Dg
stenoses during predilatation. C - Cine angiography of LAD/Dg after PCI. D - The guide-wire tip before removal from Dg. Dg,
diagonal branch; LAD, left anterior descending; PCI, percutaneous coronary intervention.
Fig. (2). Fluoroscopic images of Dg perforation. A - Contrast extravasation projecting distal part of Dg. B - Contrast extravasation in
the pericardial sac. C - The cessation of contrast extravasation in cine angiography. Dg, diagonal branch.
3. DISCUSSION
Stathopoulos et al. demonstrated that among 23,399 patients after PCI, CAP occurred in 73 patients (0.31%) [4].
CAP rates were recorded for guide-wire related CAP in 31 patients, balloon/stent-related in 46.5%, cutting the balloon
in 5.47%, rotational atherectomy devices in 4.1% and other causes in 1.37% of patients [4]. Among the culprit guide-
wires which caused CAP, 38.7% were “workhorse” guide-wires, 22.6% were hydrophilic guide-wires and 38.7% were
stiff guide-wires. Other researchers have reported that a hydrophilic wire was considered the culprit in the majority of
guide-wire induced CAP cases with the frequency ranging from 50 to 100% [6]. However, some studies demonstrated
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that  non-hydrophilic  guide-wires  were  mostly  responsible  for  CAP  [3].  Teis  et  al.  demonstrated  that  the  use  of
hydrophilic guide-wires was an independent risk factor of CAP for the treatment of chronic total occlusions (CTO) [5].
Hydrophilic  guide-wires  cause  increased the  risk  of  CAP due to  their  low coefficient  of  friction and ease  of  distal
migration [7].
Nowadays, in difficult and lengthy procedures, we strive to reduce radiation doses. Modern x-ray cameras have the
ability to reduce the radiation dose without restricting the visual field. In older devices it is only possible to reduce the
collimation beam and the field of view. Managing radiation exposure with older devices could result in poor visibility
of the peripheral parts of a guide-wire during the procedure. The tendency for hydrophilic guide-wires to migrate is
dangerous, and due to this fact, it is necessary to control the position of its distal parts during the procedure. Teis et al.
observed increased rates of delayed passage of blood after CAP with hydrophilic guide-wires which is usually due to
small perforation [5]. The mortality and morbidity rate after CAP reaches up to 7% [8]. During medium and long-term
follow-ups, the major adverse cardiovascular events (MACE) incidence was up to 41% and mortality rate could rise to
17% [3]. After PCI of class III CAP, mortality rises even to 19% [1]. Conventional management to treat CAP includes
prolonged balloon inflation and anticoagulation reversal with protamine [7]. Protamine use in patients with CAP seems
to be safe without increased rates of vessel/stent thrombosis [9]. Prolonged balloon inflation with a perfusion balloon
catheter  is  the  ideal  solution  for  managing  CAP.  Type  I  and  II  perforations  are  predominately  caused  by  stiff  or
hydrophilic guide-wires and tend to heal spontaneously, often requiring no more than observation [1, 2, 5, 6]. However,
some cases of type II CAP have the potential to progress into tamponades [2]. In type I and II perforations, if there are
significant extravasations, prolonged balloon inflation is beneficial [2]. If prolonged balloon inflation fails or there is a
large  type  III  perforation,  covered  stents  have  to  be  deployed  immediately  to  seal  the  perforation  and  prevent
haemopericardium [10]. In mild cases, deployment of a standard stent with narrow struts seems to be sufficient to seal
the CAP [11]. In our case of type II CAP, we were unable to deliver a balloon catheter. During the procedure we had to
implant a pericardial catheter. Due to patient stabilization and sustained muscle heart contractility in the Dg supplied
area, we decided not to implant a covered stent into the LAD. As we had difficulties with balloon catheter delivery, we
concluded that delivery of a covered stent would also be unsuccessful due to bulkiness and lack of flexibility of the
stent. Also, deployment of a covered stent in LAD would induce relatively large muscle necrosis. Covered stents serve
as optimal treatment for CAP occurring in large epicardial arteries involving proximal and mid segments [10]. Recently,
highly deliverable pericardial covered stents have been used in CAP [12]. If covered stents fail, patients require urgent
surgical intervention, which is accompanied by high morbidity and mortality [5]. The incidence of subacute thrombosis
and restenosis associated with covered stents is relatively higher than in the case of standard stents [13]. Another option
is  new  generation  pericardial-covered  stent  implantation  [12].  Operative  repair  of  CAP  includes  either  ligation  or
suturing of the vessel for haemostasis and bypass grafting to the distal vessel [14]. In addition, pericardial patch/teflon
felt wrapping repair of the perforation with or without coronary artery bypass grafting (CABG) is advocated especially
when multiple stents with CAP and subepicardial haematoma are present [14]. The use of metal coils, gel foam or other
embolization materials is another option for endovascular treatment of CAP [14]. It was confirmed that pericardial drain
insertion, usually for class III CAP, was a strong risk factor for subsequent death [1]. However, in patients with class II
CAP, there were no deaths and no need for pericardial drain insertion or urgent CABG [1]. The seriousness of class III
CAPs was confirmed in several studies, and in most cases of class III CAP (all pericardiocentesis) – patients underwent
emergency bypass surgery and died [3].
CONCLUSION
This case suggests that in some cases, more aggressive endovascular treatment of CAP during the acute phase could
decrease  the  probability  of  future  radical  surgical  treatment.  However,  conservative  options  for  the  percutaneous
treatment  of  CAP, the aim of which is  to avoid necrosis  of  the heart  muscle,  is  associated with increased risk of  a
subsequent need for surgical intervention in the future. Accurate primary assessment of CAP seriousness and careful
observation after PCI could improve results and lead to avoiding severe complications.
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